Effects of Eltoprazine on Cognitive Impairment Associated With Schizophrenia (CIAS) in Adults
Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if eltoprazine (as an adjunct to anti-psychotic
medication) improves one or more aspects of cognitive impairment in adult schizophrenic
patients.